Webcast - Replay Array BioPharma Inc. at Bank of America Merrill Lynch Health Care Conference 05/16/13 at 11:20 p.m. PT

Receive E-mail Alerts

RSS Feeds

Keyword Search

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

12/27/12 Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference 12/10/12 Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting 12/05/12 Array BioPharma Announces Exercise And Closing Of Underwriters' Over-Allotment Option 11/15/12 Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference 11/09/12 Array BioPharma Announces Pricing Of Public Offering Of Common Stock 11/08/12 Array BioPharma Announces Proposed Public Offering Of Common Stock 11/08/12 MEK162 Registration Path Announced 11/07/12 John A. Orwin Joins Array BioPharma Board Of Directors 11/07/12 Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences 11/06/12 Array BioPharma To Present Clinical Data On ARRY-797 At The 2012 American College Of Rheumatology Annual Meeting 11/05/12 Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor 11/01/12 Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts 10/29/12 Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2013 10/23/12 Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2013 On October 29, 2012 09/11/12 Array BioPharma to Present at the UBS Global Life Sciences Conference 08/31/12 Array BioPharma Announces Changes to Board of Directors 08/29/12 Array BioPharma to Present at the Stifel Nicolaus Healthcare, NewsMakers in the Biotech Industry and Morgan Stanley Global Healthcare Conferences 08/13/12 Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 08/06/12 Array BioPharma to Report Financial Results for the Fourth Quarter and Full Year of Fiscal 2012 on August 13, 2012 07/31/12 Array BioPharma’s ARRY-797 Meets Primary Endpoint in Clinical Proof of Concept Trial in Osteoarthritis Patients Whose Pain is Poorly Controlled by NSAIDs 07/24/12 Array BioPharma Names Andrew Robbins as Senior Vice President, Commercial Operations 07/19/12 Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes Collaboration 07/16/12 Clovis Oncology and Array BioPharma Announce Agreement to Discover Novel Mutant KIT Inhibitor 07/03/12 Array BioPharma to Present at the JMP Securities Healthcare Conference 2012 06/04/12 Promising Data for KRAS Mutant Advanced NSCLC Patients Presented at ASCO 06/04/12 MEK162 Shows Promising Clinical Activity in Ongoing Phase 2 Trial 05/30/12 Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference 05/16/12 Array BioPharma Announces Clinical Data Presentations at the 2012 ASCO Annual Meeting 05/14/12 Array BioPharma and Genentech's Strategic Alliance Voted Breakthrough Alliance of 2012 04/30/12 Array BioPharma Names Liam Ratcliffe, M.D., Ph.D., to Board of Directors 04/30/12 Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2012 04/26/12 Array BioPharma Names Ron Squarer Chief Executive Officer 04/23/12 Array BioPharma to Report Financial Results for the Third Quarter of Fiscal 2012 on April 30, 2012 04/16/12 Array BioPharma Names Howard Holden, Ph.D., Vice President of Regulatory Affairs and Quality Assurance 04/04/12 Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer 03/31/12 Selumetinib Controlled Recurrent Low-grade Serous Ovarian Cancer 02/27/12 Array BioPharma to Present at the Cowen and Company 32nd Annual Health Care Conference 02/14/12 Array BioPharma Announces Closing of Public Offering of Common Stock and Exercise of Overallotment Option 02/09/12 Array BioPharma to Present at the Leerink Swann Global Healthcare Conference 02/08/12 Array BioPharma Announces Proposed Public Offering of Common Stock 01/30/12 Array BioPharma Names Gwen A. Fyfe, M.D. to Board of Directors 01/30/12 Array BioPharma Reports Financial Results for the Second Quarter of Fiscal 2012 01/23/12 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012 01/16/12 Array BioPharma's Chief Executive Officer Robert E. Conway Resigns 01/04/12 Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference